Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma
Interventions
DEVICE:
FLT-PET
Sponsor
Barbara Ann Karmanos Cancer Institute
Collaborators
[object Object]